Clinical Trial Update: Predictive Factors of Complete Response to Immunotherapy in Metastatic Melanoma: a Single-center Retrospective Study Between 2013 and 2021

View source ↗

Summary

A single-center retrospective study from University Hospital Strasbourg (2013–2021) examines factors that predict complete response to immunotherapy in melanoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Stage III Melanoma | Status: RECRUITING